Ads
related to: treatment for pulmonary embolism journal listwexnermedical.osu.edu has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Surgical embolectomy for massive pulmonary embolism (PE) has become a rare procedure and is often viewed as a last resort. Thrombolytic therapy has become the treatment of choice. [1] Surgical or catheter embolectomy is a procedure performed in patients with pulmonary embolism, which is a blockage of an artery in the lung caused by a blood clot.
Prevalence of Non-Bronchial Systemic Culprit Arteries in Patients with Hemoptysis with Bronchiectasis and Chronic Pulmonary Infection Who Underwent De Novo Bronchial Artery Embolization - The study described the relationship between bleeding sites (pulmonary lobes) and targeted non-bronchial systemic arteries in patients with hemoptysis due to ...
Embolization refers to the passage and lodging of an embolus within the bloodstream. It may be of natural origin (pathological), in which sense it is also called embolism, for example a pulmonary embolism; or it may be artificially induced (therapeutic), as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor ...
The pulmonary embolism rule-out criteria (PERC) helps assess people in whom pulmonary embolism is suspected, but unlikely. Unlike the Wells score and Geneva score , which are clinical prediction rules intended to risk stratify people with suspected PE, the PERC rule is designed to rule out the risk of PE in people when the physician has already ...
Surgery is indicated in patients with pulmonary artery emboli that are surgically accessible. Thrombi are usually the cause of recurrent/chronic pulmonary emboli and therefore of chronic thromboembolic pulmonary hypertension (CTEPH). [2] PTE is the only definitive treatment option available for CTEPH. [3]
Alteplase, sold under the brand name Activase among others, is a biosynthetic form of human tissue-type plasminogen activator (t-PA). It is a thrombolytic medication used to treat acute ischemic stroke, acute ST-elevation myocardial infarction (a type of heart attack), pulmonary embolism associated with low blood pressure, and blocked central venous catheter. [5]
In contrast to surgical embolectomy for acute PE, treatment of CTEPH necessitates a true bilateral endarterectomy (removal of blockage from the blood vessels) through the medial layer of the pulmonary arteries, which is performed under deep hypothermia (lowering of body temperature) and circulatory arrest (temporary stoppage of blood flow), [16 ...
Professor Bounameaux research interests are broad and include studies on Non-invasive vascular diagnosis, venous thromboembolism and pulmonary embolism & Cardiology, Angiology, Hemostasis. [ 3 ] [ 9 ] His main contribution to the field relates to the non-invasive work-up of suspected pulmonary embolism, particularly the use of fibrin D-dimer.